Fibromyalgia Treatment Market
According to Intent Market Research, the Fibromyalgia Treatment Market is expected to grow from USD 2.7 Billion in 2023 at a CAGR of 7.4% to touch USD 4.5 Billion by 2030. The Fibromyalgia Treatment Market is dominated by key players such as Allergan (AbbVie Inc.), Amgen Inc., Boehringer Ingelheim, Dr. Reddy's Laboratories, Eli Lilly and Company, GSK plc, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.